REG - Bank of NY Mel Corp Medtronic, Inc. - Form 8.3 - Medtronic Inc. <Origin Href="QuoteRef">MDT.N</Origin>

MedtronicAnnouncement

29/10/2014 12:20

RNS Number : 4172U
Bank of New York Mellon Corp. (The)
15 October 2014
Ap19
FORM8.3
IRISHTAKEOVERPANEL
DISCLOSUREUNDERRULE8.3OFTHEIRISHTAKEOVERPANEL ACT,1997,TAKEOVERRULES,2013
DEALINGSBYPERSONSWITHINTERESTSINRELEVANTSECURITIESREPRESENTING1%ORMORE
1. KEYINFORMATION
Nameofpersondealing(Note1)
The Bank of New York Mellon Corporation and its subsidiaries; 1. The Bank of New York Mellon, 2. The Dreyfus Corporation, 3. BNY Mellon Service Kapitalanlage-Gesellschaft mbH, 4. Lockwood Advisors, Inc. 5. Mellon Capital Management Corporation, 6. BNY Mellon Trust Company (Cayman) Limited, 7. BNY Mellon Trust of Delaware, 8. BNY Mellon, National Association, 9. The Boston Company Asset Management LLC, 10. MBSC Securities Corporation, 11. BNY Mellon Capital Markets, LLC 12. Newton Investment Management Limited, 13. Newton Capital Management Limited
Companydealtin
Medtronic Inc
Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate(Note2)
$0.10 Common Shares
Dateofdealing
14 October 2014
2. INTERESTSANDSHORTPOSITIONS
(a) Interestsandshortpositions(followingdealing)intheclassofrelevantsecuritydealtin(Note3)

Long
Short

Number

(%)
Number

(%)
(1)Relevantsecurities
17,119,781 1.75%

(2)Derivatives(otherthanoptions)


(3)Optionsandagreementstopurchase/sell


Total
17,119,781 1.75%

(b) Interestsandshortpositionsinrelevantsecuritiesofthecompany,otherthantheclassdealtin(Note3)
Classofrelevantsecurity:
Long
Short

Number

(%)
Number

(%)
(1)Relevantsecurities


(2)Derivatives(otherthanoptions)


(3)Optionsandagreementstopurchase/sell


Total



Ap20
1. DEALINGS(Note4)
(a) Purchasesandsales
Purchase/sale
Numberofrelevantsecurities
Priceperunit(Note5)
Purchase 
Sale 
Sale 
Purchase 
Transfer Out 
Purchase
3,769
3,857
360
2,285
19,468
120
63.63
63.53
63.87
63.5
N/A
63.51
(b) Derivativestransactions(otherthanoptionstransactions)
Productname,
e.g.CFD
Natureoftransaction
(Note6)
Numberofrelevantsecurities
(Note7)
Priceperunit
(Note5)




(c) Optionstransactionsinrespectofexistingrelevantsecurities
(i) Writing,selling,purchasingorvarying
Productname,
e.g.calloption
Writing,selling,purchasing,varyingetc.
Numberofsecurities towhichtheoptionrelates(Note7)
Exercise price
Type,e.g.American,Europeanetc.
Expiry date
Optionmoney paid/receivedperunit(Note5)







(ii) Exercising
Productname,
e.g.calloption
Numberofsecurities
Exercisepriceper unit(Note5)



(d) Otherdealings(includingtransactionsinrespectofnewsecurities)(Note4)
Natureoftransaction
(Note8)
Details
Priceperunit
(if applicable) (Note 5)



Ap21
2. OTHERINFORMATION
Agreements,arrangementsorunderstandingsrelatingtooptionsorderivatives
Fulldetailsofanyagreement,arrangementorunderstandingbetweenthepersondisclosing andanyotherpersonrelatingtothevotingrightsofanyrelevantsecuritiesunderanyoption referredtoonthisformorrelatingtothevotingrightsorfutureacquisitionordisposalofanyrelevant
securitiestowhichanyderivativereferredtoonthisformisreferenced.Ifnone,this shouldbestated.
 None
IsaSupplementalForm8attached?(Note9) NO
Dateofdisclosure
15 October 2014
Contactname
Ivan Arias
Telephonenumber
1-516-338-3370
IfaconnectedEFM,nameofofferee/offerorwithwhichconnected

IfaconnectedEFM,statenatureofconnection(Note10)


This information is provided by RNS
The company news service from the London Stock Exchange
  END
ISELLFFSILLELIS